03 maj: UPDATE: Harvey Norman Issues Profit Warning; Discounting, A$ Hit ..
03 maj: Metro AG Confirms 2012 Guidance, 1Q Net Loss Widens On Year
03-05-2012 08:22:00

Antofagasta Copper Output Up, But Suffers Esperanza Setback

Relateret indhold

By Alex MacDonald

Of DOW JONES NEWSWIRES

ST. GALLEN, Switzerland -(Dow Jones)- Chilean miner Antofagasta PLC (ANTO.LN) said Thursday that first quarter copper production rose on year thanks to the ramp-up of its Esperanza mine, but fell on quarter after the mine suffered a glitch which will make it hard for miner to top the mine's previously-guided production range.

The U.K.-listed miner also raised the capital expenditure estimate for its Antucoya project to $1.4 billion from $1.3 billion after having previously flagged the fact that a tight labor market is making contract work more expensive. The 80,000 ton-a-year copper cathode project is still slated to start production in the second half of 2014.

The FTSE-100 miner said copper output rose 25.5% on year but fell 12.9% on quarter to 162,900 metric tons, mainly due to planned maintenance and expected lower grades at its Los Pelambres mine and lower ore throughput at Esperanza in February and March due to damage to the feed conveyor which was repaired by the end of March.

Antofagasta said Esperanza will still produce within the previously-guided range of 160,000 to 175,000 tons of copper and 240,000 to 260,000 ounces of gold for 2012, "albeit at the lower end of these ranges."

Expected production levels at the other three mines remains in line with its previous forecast, it added.

Antofagasta said in March that it was targeting 700,000 tons of total copper production and 280,000 ounces of gold output in 2012.

-By Alex MacDonald, Dow Jones Newswires; +44 (0)7776 200 924 alex.macdonald@dowjones.com

(END) Dow Jones Newswires

May 03, 2012 02:22 ET (06:22 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Lundbeck: Eli Lilly og Astrazeneca på vej med Alzheimers-middel

16-09-2014 16:29:37
Eli Lilly og Astrazeneca har indgået et partnerskab for at udvikle en mulig behandling til Alzheimers sygdom, fortæller medicinalvirksomhederne i en fælles medd..

Novo: Tresiba giver bedre blosukkerregulering til børn og unge

16-09-2014 12:38:17
Novo Nordisks langtidsvirkende insulinprodukt Tresiba i kombination med Novolog kan give forbedret langsigtet blodsukkerregulering hos børn og unge med type 1-d..

Aktier/middag: TDC retter sig i kedeligt marked

16-09-2014 11:43:28
De røde tal er tirsdag i klar overvægt på fondsbørsen i København, hvor mange investorer har valgt at blive på sidelinjen for at afvente onsdagens rentemøde i U..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Mærsk/Macquarie: Løfter kursmål til 20.400 kr. fra 17.600 kr.
2
Aktier/tendens: TDC i fortsat fokus på "mellemdag"
3
UK/Danske: Skotsk "ja" med mulige konsekvenser
4
Torm/fmd: Udvanding af aktionærerne forventelig
5
Novo: Tresiba giver bedre blosukkerregulering til børn og unge

Relaterede aktiekurser

Antofagasta PLC 762,00 0,1% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
17. september 2014 01:29:55
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140915.2 - EUROWEB6 - 2014-09-17 01:29:55 - 2014-09-17 01:29:55 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x